Supporting the designation of March 2026 as Endometriosis Awareness Month.
- Bill Number
- H.Res. 1200
- Origin Chamber
- House
- Congress
- 119th Congress, Session 2
- Status
- Introduced
- Latest Action
- 2026-04-20: Referred to the House Committee on Energy and Commerce.
- Last Updated
- 2026-04-21T08:19:08Z
AI-Generated Summary
Purpose
This House Resolution (H. Res. 1200) expresses support for designating March 2026 as Endometriosis Awareness Month. It highlights the prevalence, challenges, and impacts of endometriosis—a condition where tissue similar to the uterine lining grows outside the uterus—affecting about 1 in 10 women of reproductive age.
Key Provisions
The resolution includes extensive background ("Whereas" clauses) on endometriosis, such as:
- Unknown cause but known risk factors (e.g., family history, early or heavy periods).
- Diagnosis challenges: Often requires surgery (laparoscopy); average delay of 3–11 years; 75% misdiagnosis rate.
- Symptoms and effects: Chronic pain, infertility, reduced quality of life, work/school impacts (e.g., 11 lost work hours/week, 18 bed days/year), high costs ($13,000+ per patient annually).
- Treatment limitations: No cure; options include surgery, medications like GnRH antagonists; need for more research and guidelines.
The core actions ("Resolved" clauses) urge the House to:
- Support the goals of Endometriosis Awareness Month.
- Promote early detection, treatment, provider education, and culturally competent care.
- Commit to funding research for better treatments, fertility support, and a cure.
- Encourage public awareness and educational activities.
Significant Changes to Existing Law
- None. This is a non-binding resolution, not a law. It does not amend statutes, create mandates, or allocate funds.
Potential Impacts
- Citizens: Increased public awareness may lead to earlier diagnosis and better management for affected women and girls, potentially improving quality of life, work productivity, and reducing healthcare costs.
- Government agencies: Signals congressional interest in prioritizing endometriosis research (e.g., via CDC, NIH), but no direct funding or requirements.
- Healthcare system: Encourages provider education and research, possibly reducing misdiagnoses and long-term burdens.
- No international relations impact.
Main Stakeholders Affected
- Women and girls with endometriosis (primary patients, facing pain, infertility, career setbacks).
- Families (e.g., those with genetic risk factors).
- Healthcare providers (need for better education and guidelines).
- Researchers and medical societies (call for more studies and treatments).
- Patient advocacy groups (support for public education).
- Employers and schools (impacted by productivity losses).
Notable Legal, Constitutional, or Political Implications
- Symbolic and bipartisan: Sponsored by members from both parties (e.g., Mr. David Scott, Mrs. Miller-Meeks), referred to House Committee on Energy and Commerce; fosters unity on women's health without controversy.
- No legal enforceability: As a simple resolution, it expresses House opinion only, with no Senate or presidential involvement.
- Political signal: Reinforces commitment to women's health research amid calls for addressing "unmet needs," potentially influencing future funding bills.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (3)
Rep. Miller-Meeks, Mariannette [R-IA-1], Rep. Williams, Nikema [D-GA-5], Rep. Crenshaw, Dan [R-TX-2]
Recent Actions
- 2026-04-20: Referred to the House Committee on Energy and Commerce.
- 2026-04-20: Submitted in House
Bill Versions
- Supporting the designation of March 2026 as Endometriosis Awareness Month. — issued 2026-04-20 — PDF (4 pages)